Belén Pérez

Also affiliated with Universidad de Alcalá, Hospital La Paz Institute for Health Research, Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Biología Molecular Severo Ochoa, Instituto de Investigación de Enfermedades Raras, Hospital Universitario Ramón y Cajal, Universidad Autónoma de Madrid

MedicineMaterials ScienceComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain”.

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain

Journal of Enzyme Inhibition and Medicinal Chemistry(2025)10.1080/14756366.2025.2574990

N/A

0.104DataRank · unranked

1 citations

Beatrice Jora, Miriam Santos-Caballero, Qiongju Qiu, Carla Calvó‐Tusell, Celia Escriche +21 more

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Neurotherapeutics(2020)10.1007/s13311-020-00854-1

N/A

0DataRank · unranked

88 citations

Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano +13 more

Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents

ChemMedChem(2022)10.1002/cmdc.202200002

N/A

0DataRank · unranked

12 citations

Bhanwar Singh Choudhary, Júlia Companys‐Alemany, Sukanya Sukanya, Pedro Antonio Ávila-López, Antón L. Martínez +6 more

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01367

N/A

0DataRank · unranked

18 citations

Alicia Porro-Pérez, Linda Schäker‐Hübner, Fernando Romero, Min Dong, Abdelouahid Samadi +29 more

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.038

N/A

0DataRank · unranked

2 citations

David Valle-Garcia, Carla Barbaraci, Fernando Romero-Becerra, Rohit Kumar Singh, Júlia Jarne-Ferrer +34 more